16
GASTROINTESTINAL DISORDERS
Gastricumeel as effective as PPIs in improving overall condition, and in overall assessment by the physician2
Clinical Effectiveness*
Change overall condition**
20
40
60
100
%
80
** P-value (between group differences) not significant
very much better much better slightly better worse not assessableunchanged
PPIs (n=193)
Gastricumeel (n=434)
Overall assessment of effectiveness of the therapy**
20
40
60
100
%
80
** P-value (between group differences) not significant
very good good satisfactory worsened not assessableno improvement
PPIs (n=183)
Gastricumeel (n=434)
Assessment of change in overall condition and overall therapy effectiveness were done at the end of the observation period
* Patients with dyspepsia (suspected new or recurring acute or chronic gastritis) or heartburn
References 2) Van Haselen, R., Cesnulevicius, K. Treatment of Dyspepsia, Heartburn, and Related Symptoms with Gastricumeel Compared to Proton Pump Inhibitors: A Prospective
Reference-Controlled Observational Study. Complement Med Res (2020): DOI: 10.1159/000511285. Online link: https://www.karger.com/Article/Fulltext/511285